[1]
|
Yao, M., Ni, J., Zhou, L., et al. (2016) Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART. PLoS ONE, 11, e0160674.
https://doi.org/10.1371/journal.pone.0160674
|
[2]
|
Budoff, M. (2016) Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. The American Journal of Cardiology, 118, 138-145. https://doi.org/10.1016/j.amjcard.2016.04.004
|
[3]
|
Deng, X., Liu, Z., Wang, C., et al. (2017) Insulin Resistance in Ischemic Stroke. Metabolic Brain Disease, 32, 1323-1334. https://doi.org/10.1007/s11011-017-0050-0
|
[4]
|
Stringer, D., Zahradka, P. and Taylor, C. (2015) Glucose Transporters: Cellular Links to Hyperglycemia in Insulin Resistance and Diabetes. Nutrition Reviews, 73, 140-154. https://doi.org/10.1093/nutrit/nuu012
|
[5]
|
Mikhail, N. (2009) The Metabolic Syndrome: Insulin Resistance. Current Hypertension Reports, 11, 156-158.
https://doi.org/10.1007/s11906-009-0027-4
|
[6]
|
Shannon, C., Merovci, A., Xiong, J., et al. (2018) Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects with Normal Glucose Tolerance. Diabetes, 67, 2507-2517. https://doi.org/10.2337/db18-0439
|
[7]
|
Ferrannini, E., Barrett, E., Bevilacqua, S., et al. (1983) Effect of Fatty Acids on Glucose Production and Utilization in Man. The Journal of Clinical Investigation, 72, 1737-1747. https://doi.org/10.1172/JCI111133
|
[8]
|
Vasques, A., Novaes, F., de Oliveira, M.S., et al. (2011) TyG Index Performs Better than HOMA in a Brazilian Population: A Hyperglycemic Clamp Validated Study. Diabetes Research and Clinical Practice, 93, e98-e100.
https://doi.org/10.1016/j.diabres.2011.05.030
|
[9]
|
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南[J]. 中华神经科杂志, 2015, 48(4): 246-257.
|
[10]
|
James, P., Oparil, S., Carter, B., et al. (2014) 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311, 507-520. https://doi.org/10.1001/jama.2013.284427
|
[11]
|
Guerrero-Romero, F., Simental-Mendía, L., González-Ortiz, M., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology and Metabolism, 95, 3347-3351. https://doi.org/10.1210/jc.2010-0288
|
[12]
|
Simental-Mendía, L., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. https://doi.org/10.1089/met.2008.0034
|
[13]
|
Muchada, M., Rubiera, M., Rodriguez-Luna, D., et al. (2014) Baseline National Institutes of Health Stroke Scale-Adjusted Time Window for Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke. Stroke, 45, 1059-1063. https://doi.org/10.1161/STROKEAHA.113.004307
|
[14]
|
王栋梁, 李新, 王纪佐. 2030例急性脑梗死患者合并代谢综合征临床特点分析[J]. 国际脑血管病杂志, 2010(10): 730-734.
|
[15]
|
Suzuki, L., Poot, M., Gerrity, R., et al. (2001) Diabetes Accelerates Smooth Muscle Accumulation in Lesions of Atherosclerosis: Lack of Direct Growth-Promoting Effects of High Glucose Levels. Diabetes, 50, 851-860.
https://doi.org/10.2337/diabetes.50.4.851
|
[16]
|
Wu, G. and Meininger, C. (2009) Nitric Oxide and Vascular Insulin Resistance. BioFactors (Oxford, England), 35, 21-27. https://doi.org/10.1002/biof.3
|
[17]
|
Ozkul, A., Turgut, E., Akyol, A., et al. (2010) The Relationship between Insulin Resistance and Hypercoagulability in Acute Ischemic Stroke. European Neurology, 64, 201-206. https://doi.org/10.1159/000319196
|
[18]
|
Reaven, G. (1995) Pathophysiology of Insulin Resistance in Human Disease. Physiological Reviews, 75, 473-486.
https://doi.org/10.1152/physrev.1995.75.3.473
|
[19]
|
Moore, S., Williams, C., Brown, E., et al. (2015) Loss of the Insulin Receptor in Murine Megakaryocytes/Platelets Causes Thrombocytosis and Alterations in IGF Signalling. Cardiovascular Research, 107, 9-19.
https://doi.org/10.1093/cvr/cvv132
|
[20]
|
Santilli, F., Vazzana, N., Liani, R., et al. (2012) Platelet Activation in Obesity and Metabolic Syndrome. Obesity Reviews, 13, 27-42. https://doi.org/10.1111/j.1467-789X.2011.00930.x
|
[21]
|
Flemming, K. and Brown, R. (2004) Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors. Mayo Clinic Proceedings, 79, 1330-1340. https://doi.org/10.4065/79.10.1330
|
[22]
|
Chiu, C., Wu, S., Lee, P., et al. (2008) Control of Modifiable Risk Factors in Ischemic Stroke Outpatients by Pharmacist Intervention: An Equal Allocation Stratified Randomized Study. Journal of Clinical Pharmacy and Therapeutics, 33, 529-535. https://doi.org/10.1111/j.1365-2710.2008.00940.x
|
[23]
|
Irace, C., Carallo, C., Scavelli, F., et al. (2013) Markers of Insulin Resistance and Carotid Atherosclerosis. A Comparison of the Homeostasis Model Assessment and Triglyceride Glucose Index. International Journal of Clinical Practice, 67, 665-672. https://doi.org/10.1111/ijcp.12124
|